North Atlantic Titanium files NI 43-101 technical report for Everett titanium project in Québec
Bitget2026/10/08 12:42North Atlantic Titanium filed an NI 43-101 technical report on the Everett Titanium Project in Québec, prepared by Micon International. Work to date supports a continuous titanium-vanadium-phosphate intrusion extending at least 2.5 km, with mineralization trending farther north. No current mineral resource estimate; the report recommends staged exploration ahead of an initial estimate. Two-phase program targets up to 25,000 meters of diamond drilling; total budget estimated at $13.65 million before taxes. Phase 1 budgeted at $4.12 million including contingency; Phase 2 estimated at $9.53 million including contingency, subject to results. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. North Atlantic Titanium Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202610080840TNWSWRCACNPR_____1ArbFabV5) on October 08, 2026, and is solely responsible for the information contained therein.
- North Atlantic Titanium filed an NI 43-101 technical report on the Everett Titanium Project in Québec, prepared by Micon International.
- Work to date supports a continuous titanium-vanadium-phosphate intrusion extending at least 2.5 km, with mineralization trending farther north.
- No current mineral resource estimate; the report recommends staged exploration ahead of an initial estimate.
- Two-phase program targets up to 25,000 meters of diamond drilling; total budget estimated at $13.65 million before taxes.
- Phase 1 budgeted at $4.12 million including contingency; Phase 2 estimated at $9.53 million including contingency, subject to results.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
